249 related articles for article (PubMed ID: 24465606)
1. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity.
Muramatsu M; Yoshida R; Yokoyama A; Miyamoto H; Kajihara M; Maruyama J; Nao N; Manzoor R; Takada A
PLoS One; 2014; 9(1):e85582. PubMed ID: 24465606
[TBL] [Abstract][Full Text] [Related]
2. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
3. Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.
Muramatsu M; Yoshida R; Miyamoto H; Tomabechi D; Kajihara M; Maruyama J; Kimura T; Manzoor R; Ito K; Takada A
PLoS One; 2013; 8(8):e71534. PubMed ID: 23977065
[TBL] [Abstract][Full Text] [Related]
4. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
5. [In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus].
Argentova VV; Aliev TK; Zarubaev VV; Klotchenko SA; Shtro AA; Sergeeva MV; Toporova VA; Dolgikh DA; Sveshnikov PG; Vasin VA; Kirpichnikov MP
Mol Biol (Mosk); 2017; 51(6):927-937. PubMed ID: 29271957
[TBL] [Abstract][Full Text] [Related]
6. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analyses of the Antiviral Activities of IgG and IgA Antibodies to Influenza A Virus M2 Protein.
Okuya K; Eguchi N; Manzoor R; Yoshida R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Miyamoto H; Ichii O; Kajihara M; Higashi H; Takada A
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698456
[TBL] [Abstract][Full Text] [Related]
8. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody.
Saito S; Sano K; Suzuki T; Ainai A; Taga Y; Ueno T; Tabata K; Saito K; Wada Y; Ohara Y; Takeyama H; Odagiri T; Kageyama T; Ogawa-Goto K; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
PLoS Pathog; 2019 Jan; 15(1):e1007427. PubMed ID: 30605488
[TBL] [Abstract][Full Text] [Related]
9. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs.
Seibert CW; Rahmat S; Krause JC; Eggink D; Albrecht RA; Goff PH; Krammer F; Duty JA; Bouvier NM; García-Sastre A; Palese P
J Virol; 2013 Jul; 87(14):7793-804. PubMed ID: 23698296
[TBL] [Abstract][Full Text] [Related]
10. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of intracellular specific IgA (icIgA) with influenza virus in patients' nasopharyngeal aspirate cells.
Kok TW; Costabile M; Tannock GA; Li P
J Virol Methods; 2018 Feb; 252():8-14. PubMed ID: 29102516
[TBL] [Abstract][Full Text] [Related]
12. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
13. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
14. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
[TBL] [Abstract][Full Text] [Related]
15. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
16. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
17. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.
Tamura S; Funato H; Hirabayashi Y; Kikuta K; Suzuki Y; Nagamine T; Aizawa C; Nakagawa M; Kurata T
Vaccine; 1990 Oct; 8(5):479-85. PubMed ID: 2251874
[TBL] [Abstract][Full Text] [Related]
18. A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.
Manzoor R; Eguchi N; Yoshida R; Ozaki H; Kondoh T; Okuya K; Miyamoto H; Takada A
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055251
[TBL] [Abstract][Full Text] [Related]
19.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
20. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
